Beryl Drugs Limited (BOM:524606)
India flag India · Delayed Price · Currency is INR
22.11
+0.23 (1.05%)
At close: Feb 12, 2026

Beryl Drugs Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
5.797.697.66-6.592.4
Depreciation & Amortization
12.46128.1410.8712.74
Other Amortization
00---
Loss (Gain) From Sale of Assets
--0.11---
Loss (Gain) From Sale of Investments
-----4.52
Other Operating Activities
5.033.774.65-0.434.09
Change in Accounts Receivable
21.27-6.84-24.520.92-10.87
Change in Inventory
-6.43-2.0619.24-7.09-11.12
Change in Accounts Payable
-9.01-12.321.91-0.474.18
Change in Other Net Operating Assets
-2.756.066.83-1.896.48
Operating Cash Flow
26.378.223.91-4.693.39
Operating Cash Flow Growth
221.46%-65.70%--83.18%
Capital Expenditures
-21.85-13.52-15.64-4.16-16.72
Sale of Property, Plant & Equipment
-0.21---
Investment in Securities
-2.19--9.72
Other Investing Activities
17.880.33.869.49.55
Investing Cash Flow
-3.97-10.82-11.775.242.55
Short-Term Debt Issued
-7.97-4.81-
Long-Term Debt Issued
12.48-11.5216.757.6
Total Debt Issued
12.487.9711.5221.567.6
Short-Term Debt Repaid
-3.62--17.84--
Long-Term Debt Repaid
-19.07-2.45-1.2-19.86-8.32
Total Debt Repaid
-22.69-2.45-19.04-19.86-8.32
Net Debt Issued (Repaid)
-10.215.52-7.521.7-0.72
Other Financing Activities
-5.3-4.49-4.51-4.06-4.66
Financing Cash Flow
-15.51.03-12.02-2.36-5.38
Miscellaneous Cash Flow Adjustments
-00--
Net Cash Flow
6.89-1.580.12-1.810.56
Free Cash Flow
4.52-5.318.28-8.84-13.33
Free Cash Flow Margin
2.14%-1.99%3.08%-6.05%-9.46%
Free Cash Flow Per Share
0.89-1.051.63-1.74-2.63
Cash Interest Paid
5.184.454.163.974.66
Cash Income Tax Paid
1.820.610.310.22
Levered Free Cash Flow
2.36-11.53-4.51-4.9-16.47
Unlevered Free Cash Flow
5.61-8.73-1.9-2.28-13.8
Change in Working Capital
3.09-15.153.46-8.53-11.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.